ATE102030T1 -
USE OF KETAMINE IN THE MANUFACTURE OF MEDICATIONS FOR PREVENTING OR REDUCING THE EFFECTS OF STROKE IN A PERSON AT HIGH RISK OF STROKE.
- Google Patents
USE OF KETAMINE IN THE MANUFACTURE OF MEDICATIONS FOR PREVENTING OR REDUCING THE EFFECTS OF STROKE IN A PERSON AT HIGH RISK OF STROKE.
Info
Publication number
ATE102030T1
ATE102030T1AT87110690TAT87110690TATE102030T1AT E102030 T1ATE102030 T1AT E102030T1AT 87110690 TAT87110690 TAT 87110690TAT 87110690 TAT87110690 TAT 87110690TAT E102030 T1ATE102030 T1AT E102030T1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority claimed from EP87110690Aexternal-prioritypatent/EP0254313B1/en
Application grantedgrantedCritical
Publication of ATE102030T1publicationCriticalpatent/ATE102030T1/en
AT87110690T1986-07-241987-07-23
USE OF KETAMINE IN THE MANUFACTURE OF MEDICATIONS FOR PREVENTING OR REDUCING THE EFFECTS OF STROKE IN A PERSON AT HIGH RISK OF STROKE.
ATE102030T1
(en)
Use of ketamine for the manufacturing of medicaments for prevention or reduction of the effects of stroke in a subject having increased risk for stroke